Tissue Transglutaminase 2 Catalyzed Cross-Links Between Lysine and Glutamine in α-Synuclein Induced Neurodegenerative Diseases

dc.contributor.advisorWidger, William R.
dc.contributor.committeeMemberSater, Amy K.
dc.contributor.committeeMemberGunaratne, Preethi H.
dc.contributor.committeeMemberMerchant, Fatima Aziz
dc.creatorRobertson, Patricia C.
dc.date.createdDecember 2022
dc.description.abstractA common hallmark associated in neurodegenerative diseases (ND) are the appearance of abnormal proteins, such as mutations, misfolding, cross-linking, and amino acid extensions generated by nucleotide repeats. Parkinson’s disease (PD), the 14th-leading cause of death in the United States and the second most common neurodegenerative disorder after Alzheimer’s disease (AD). PD is characterized by the progressive loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) associated with the accumulation of α-synuclein. α-synuclein is a 140 amino acid aggregate-prone protein that contributes to the development of PD, dementia, and other ND, referred to as synucleinopathies. This protein is the major constituent of Lewy bodies (LB) and LB neurites, which are pathological protein aggregates that accumulate in the nerve cells of patients with PD, PD dementia (PDD), and LB dementia (LBD) and increase throughout the nervous system during the progression of the disease. Tissue transglutaminase (TG2), a calcium-dependent enzyme that catalyzes the formation of isopeptide bonds of numerous substrates and implicated in the involvement of ND. I demonstrated TG2 was a key driver in the formation of toxic α-synuclein multimers by cross-linking specific glutamine residues into covalent, protease-resistant epsilon-gamma glutamyl lysine isopeptide bonds. Here, I employed a cost-efficient and innovative technology system that screened specific peptides at the molecular level, elucidated the amine acceptor involved in the post-translational modification (PTM) in α-synuclein aggregates by investigating the enzyme-substrate relationship catalyzed by TG2. A novel in vitro microfluidic peptide-microarray biochip (PepArray™) technology platform was used to analyze 3968 immobilized peptides for identification of specific modified glutamine residues when reacted with TG2, where substrates were available in a controlled enzymatic reaction chamber. Proteomics-based mass spectrometer Orbitrap mass analyzer coupled with an IonTrap analyzer were used to identify specific modified glutamine residues which showed cross-links of Q24 at K6, and highly reactive Q62 at K96. Identification of these disease state substrates supply an intervention into managing cluster growth and better understand the pathogenic properties of α-synucleins which influence in the progression of ND. These proteomic technologies can provide significant insights into substrate specificity and their functions through in vitro technology.
dc.description.departmentBiology and Biochemistry, Department of
dc.format.digitalOriginborn digital
dc.rightsThe author of this work is the copyright owner. UH Libraries and the Texas Digital Library have their permission to store and provide access to this work. Further transmission, reproduction, or presentation of this work is prohibited except with permission of the author(s).
dc.subjectNeurodegenerative diseases
dc.subjectParkinson's disease
dc.subjectMass spectrometry
dc.subjectMicro peparray
dc.titleTissue Transglutaminase 2 Catalyzed Cross-Links Between Lysine and Glutamine in α-Synuclein Induced Neurodegenerative Diseases
dcterms.accessRightsThe full text of this item is not available at this time because the student has placed this item under an embargo for a period of time. The Libraries are not authorized to provide a copy of this work during the embargo period.
thesis.degree.collegeCollege of Natural Sciences and Mathematics
thesis.degree.departmentBiology and Biochemistry, Department of
thesis.degree.grantorUniversity of Houston
thesis.degree.nameDoctor of Philosophy


License bundle

Now showing 1 - 2 of 2
No Thumbnail Available
4.43 KB
Plain Text
No Thumbnail Available
1.82 KB
Plain Text